1. Low Expression and Promoter Hypermethylation of the Tumour Suppressor SLIT2, are Associated with Adverse Patient Outcomes in Diffuse Large B Cell Lymphoma
   Ghada Mohamed et al, 2019, Pathology & Oncology Research CrossRef